Amsel Medical awarded $7.45M SBIR contract from U.S. Air Force

Amsel Medical Corporation has been awarded a $7.45 million sole-source SBIR Phase III contract by the U.S. Air Force to commercialize its SCureTO hemorrhage control device for combat casualty care.

“Amsel Medical Corporation today announces that it has been awarded an $7.45 million sole source, non-dilutive, small business innovative research (SBIR) Phase III contract by the United States Air Force.”prnewswire.com

• 1 source
• prnewswire.comAMSEL MEDICAL SIGNS $7.45M PHASE III SBIR CONTRACTAmsel MedicalOct 2, 2024

Summarized from public sources; check the original articles before acting on it.